SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - Euronext Milan - FR0000120578 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to 1SAN. 1SAN was compared to 53 industry peers in the Pharmaceuticals industry. 1SAN has an average financial health and profitability rating. 1SAN has a decent growth rate and is not valued too expensively. 1SAN also has an excellent dividend rating. With these ratings, 1SAN could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
1SAN has a Return On Assets of 9.00%. This is in the better half of the industry: 1SAN outperforms 69.81% of its industry peers.
1SAN's Return On Equity of 15.37% is in line compared to the rest of the industry. 1SAN outperforms 56.60% of its industry peers.
The Return On Invested Capital of 1SAN (15.58%) is better than 75.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 15.44%.
The 3 year average ROIC (7.46%) for 1SAN is below the current ROIC(15.58%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.37% | ||
| ROIC | 15.58% |
ROA(3y)5.07%
ROA(5y)6.23%
ROE(3y)8.63%
ROE(5y)10.88%
ROIC(3y)7.46%
ROIC(5y)7.05%
1.3 Margins
Looking at the Profit Margin, with a value of 12.97%, 1SAN is in the better half of the industry, outperforming 60.38% of the companies in the same industry.
1SAN's Profit Margin has improved in the last couple of years.
1SAN's Operating Margin of 22.04% is in line compared to the rest of the industry. 1SAN outperforms 54.72% of its industry peers.
1SAN's Operating Margin has improved in the last couple of years.
1SAN has a Gross Margin (70.04%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.04% | ||
| PM (TTM) | 12.97% | ||
| GM | 70.04% |
OM growth 3Y0.02%
OM growth 5Y3.47%
PM growth 3Y-6.53%
PM growth 5Y12.13%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
1SAN has less shares outstanding than it did 1 year ago.
1SAN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 3.04, which is a good value as it means it would take 1SAN, 3.04 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.04, 1SAN is in the better half of the industry, outperforming 67.92% of the companies in the same industry.
1SAN has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
1SAN has a better Debt to Equity ratio (0.17) than 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 3.04 | ||
| Altman-Z | N/A |
ROIC/WACC2.07
WACC7.54%
2.3 Liquidity
A Current Ratio of 1.46 indicates that 1SAN should not have too much problems paying its short term obligations.
1SAN has a Current ratio of 1.46. This is comparable to the rest of the industry: 1SAN outperforms 58.49% of its industry peers.
1SAN has a Quick Ratio of 1.46. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
1SAN's Quick ratio of 0.74 is on the low side compared to the rest of the industry. 1SAN is outperformed by 75.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.52%.
1SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
Looking at the last year, 1SAN shows a very strong growth in Revenue. The Revenue has grown by 30.30%.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
Revenue 1Y (TTM)30.3%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
3.2 Future
1SAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.23% yearly.
Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 4.33% on average per year.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y8.23%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.33%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.22, which indicates a correct valuation of 1SAN.
Based on the Price/Earnings ratio, 1SAN is valued a bit cheaper than 71.70% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1SAN to the average of the S&P500 Index (26.25), we can say 1SAN is valued rather cheaply.
1SAN is valuated reasonably with a Price/Forward Earnings ratio of 10.30.
Based on the Price/Forward Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 75.47% of the companies are valued more expensively.
1SAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.22 | ||
| Fwd PE | 10.3 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1SAN.
1SAN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.86 | ||
| EV/EBITDA | 10.02 |
4.3 Compensation for Growth
1SAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)2.4
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
1SAN has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 3.05, 1SAN pays a bit more dividend than its industry peers.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.34%.
Dividend Growth(5Y)4.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1SAN pays out 39.72% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.72%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
BIT:1SAN (5/21/2025, 7:00:00 PM)
93.98
+1.72 (+1.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners39.32%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap228.72B
Analysts80
Price Target121.29 (29.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend3.79
Dividend Growth(5Y)4.34%
DP39.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.16%
Min EPS beat(2)-2.18%
Max EPS beat(2)14.5%
EPS beat(4)3
Avg EPS beat(4)4.59%
Min EPS beat(4)-2.18%
Max EPS beat(4)14.5%
EPS beat(8)5
Avg EPS beat(8)2.9%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)4.38%
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-4.57%
Max Revenue beat(2)3.66%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.73%
Revenue beat(12)7
Avg Revenue beat(12)19.67%
Revenue beat(16)11
Avg Revenue beat(16)28.47%
PT rev (1m)2.99%
PT rev (3m)2.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.77%
EPS NY rev (1m)0%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.59%
Revenue NY rev (1m)-3.29%
Revenue NY rev (3m)-3.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.22 | ||
| Fwd PE | 10.3 | ||
| P/S | 2.48 | ||
| P/FCF | 38.86 | ||
| P/OCF | 25.19 | ||
| P/B | 2.94 | ||
| P/tB | 20 | ||
| EV/EBITDA | 10.02 |
EPS(TTM)7.69
EY8.18%
EPS(NY)9.13
Fwd EY9.71%
FCF(TTM)2.42
FCFY2.57%
OCF(TTM)3.73
OCFY3.97%
SpS37.83
BVpS31.92
TBVpS4.7
PEG (NY)1.46
PEG (5Y)2.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.37% | ||
| ROCE | 19.55% | ||
| ROIC | 15.58% | ||
| ROICexc | 16.79% | ||
| ROICexgc | 53.71% | ||
| OM | 22.04% | ||
| PM (TTM) | 12.97% | ||
| GM | 70.04% | ||
| FCFM | 6.39% |
ROA(3y)5.07%
ROA(5y)6.23%
ROE(3y)8.63%
ROE(5y)10.88%
ROIC(3y)7.46%
ROIC(5y)7.05%
ROICexc(3y)8.27%
ROICexc(5y)7.94%
ROICexgc(3y)35.84%
ROICexgc(5y)35.27%
ROCE(3y)9.37%
ROCE(5y)8.86%
ROICexcg growth 3Y-11.4%
ROICexcg growth 5Y0.08%
ROICexc growth 3Y1.08%
ROICexc growth 5Y3.67%
OM growth 3Y0.02%
OM growth 5Y3.47%
PM growth 3Y-6.53%
PM growth 5Y12.13%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 3.04 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 89.1% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | -34.57 | ||
| Cash Conversion | 38.03% | ||
| Profit Quality | 49.3% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | N/A |
F-Score7
WACC7.54%
ROIC/WACC2.07
Cap/Depr(3y)72.19%
Cap/Depr(5y)66.85%
Cap/Sales(3y)6.19%
Cap/Sales(5y)5.87%
Profit Quality(3y)111.96%
Profit Quality(5y)103.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y8.23%
Revenue 1Y (TTM)30.3%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.33%
EBIT growth 1Y21.75%
EBIT growth 3Y4.19%
EBIT growth 5Y6.9%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y10.86%
FCF growth 1Y-18.63%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%